Articles published by Ipsen
![](https://mms.businesswire.com/media/20230126005858/en/1151926/5/Ipsen_Logo.jpg)
![](https://mms.businesswire.com/media/20230120005252/en/1151926/5/Ipsen_Logo.jpg)
![](https://mms.businesswire.com/media/20230108005085/en/1151926/5/Ipsen_Logo.jpg)
![](https://mms.businesswire.com/media/20221223005208/en/1151926/5/Ipsen_Logo.jpg)
![](https://mms.businesswire.com/media/20221208005640/en/1151926/5/Ipsen_Logo.jpg)
![](https://mms.businesswire.com/media/20221108006021/en/1151926/5/Ipsen_Logo.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20221025005735/en/1151926/5/Ipsen_Logo.jpg)
Ipsen Statement on Updated Timeline for Palovarotene FDA Advisory Committee Meeting
October 25, 2022
From Ipsen
Via Business Wire
![](https://mms.businesswire.com/media/20220812005287/en/1151926/5/Ipsen_Logo.jpg)
From Ipsen
Via Business Wire
![](https://mms.businesswire.com/media/20220804006066/en/1151926/5/Ipsen_Logo.jpg)
From Ipsen
Via Business Wire
![](https://mms.businesswire.com/media/20220802006066/en/1151926/5/Ipsen_Logo.jpg)
![](https://mms.businesswire.com/media/20220731005021/en/1529816/5/MicrosoftTeams-image_63.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
From Ipsen
Via Business Wire
![](https://mms.businesswire.com/media/20220622005611/en/1151926/5/Ipsen_Logo.jpg)
![](https://mms.businesswire.com/media/20220609005489/en/1151926/5/Ipsen_Logo.jpg)
![](https://mms.businesswire.com/media/20220526005713/en/1151926/5/Ipsen_Logo.jpg)
![](https://mms.businesswire.com/media/20220502005679/en/1151926/5/Ipsen_Logo.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
From Ipsen
Via Business Wire
![](https://mms.businesswire.com/media/20220324005585/en/1151926/5/Ipsen_Logo.jpg)
Ipsen Receives Positive CHMP Opinion for Cabometyx® in Radioactive Iodine-refractory Differentiated Thyroid Cancer
March 25, 2022
From Ipsen
Via Business Wire
Tickers
OTC
![](https://mms.businesswire.com/media/20220315006218/en/1151926/5/Ipsen_Logo.jpg)
![](https://mms.businesswire.com/media/20220214005740/en/1151926/5/Ipsen_Logo.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Ipsen Presents Strong Full-Year 2021 Results and Enters Into Exclusive Negotiations to Divest Its Consumer Healthcare Business
February 11, 2022
From Ipsen
Via Business Wire
Tickers
OTC
![](https://mms.businesswire.com/media/20220123005045/en/1151926/5/Ipsen_Logo.jpg)
![](https://mms.businesswire.com/media/20220120006035/en/1334767/5/Karen_Witts_Photo_highres.jpg)
Ipsen Nominates Karen Witts as New Independent Board Member
January 21, 2022
From Ipsen
Via Business Wire
Tickers
OTC
![](https://mms.businesswire.com/media/20211103005117/en/1228937/5/2560px-Ipsen_logo.svg.jpg)
Ipsen Appoints Stewart Campbell Executive Vice President and President of North America
November 03, 2021
From Ipsen
Via Business Wire
Tickers
OTC
![](https://mms.businesswire.com/media/20211026006178/en/1151926/5/Ipsen_Logo.jpg)
Ipsen Pledges Ambitious Action on Climate Change
October 27, 2021
From Ipsen
Via Business Wire
Tickers
OTC
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Ipsen Delivers Strong Sales Growth for the First Nine Months and Improves Its Full-Year Guidance
October 21, 2021
From Ipsen
Via Business Wire
Tickers
OTC
![](https://mms.businesswire.com/media/20211017005063/en/1228937/5/2560px-Ipsen_logo.svg.jpg)
![](https://mms.businesswire.com/media/20211010005020/en/1151926/5/Ipsen_Logo.jpg)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.